Reported a net loss of $1.8 million for the three months ended March 31, 2026, compared to a net income of $3.0 million in the same period of 2025. Cash and cash equivalents decreased to $2.6 million as of March 31, 2026, from $3.7 million at year-end 2025. Operating expenses were $1.6 million for the quarter, driven by research and development and general administrative costs. Management explicitly states there is substantial doubt about the company's ability to continue as a going concern due to insufficient liquidity. The company is actively exploring strategic alternatives, including potential partnerships or business combinations.